Oxford Asset Management’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,589
| Closed | -$148K | – | 1978 |
|
|
2019
Q3 | $148K | Sell |
2,589
-6,020
| -70% | -$344K | ﹤0.01% | 1601 |
|
|
2019
Q2 | $406K | Sell |
8,609
-2,001
| -19% | -$94.4K | 0.01% | 1351 |
|
|
2019
Q1 | $572K | Sell |
10,610
-2,767
| -21% | -$149K | 0.01% | 1149 |
|
|
2018
Q4 | $578K | Buy |
13,377
+637
| +5% | +$27.5K | 0.02% | 1131 |
|
|
2018
Q3 | $747K | Buy |
12,740
+6,544
| +106% | +$384K | 0.02% | 1145 |
|
|
2018
Q2 | $299K | Buy |
6,196
+3,888
| +168% | +$188K | 0.01% | 1494 |
|
|
2018
Q1 | $650K | Buy |
2,308
+547
| +31% | +$154K | 0.01% | 1134 |
|
|
2017
Q4 | $419K | Buy |
+1,761
| New | +$419K | 0.01% | 1237 |
|